MOLECULIN BIOTECH INC (MBRX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.71+5.09%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MBRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 19.7 | 15.9 | 17.7 | 19.5 | 19.0 | 14.4 | 12.8 | 11.0 | 9.7 | 4.5 | 1.5 |
| Operating Income | (28.9) | (25.1) | (26.6) | (29.6) | (30.6) | (23.0) | (19.7) | (17.5) | (15.0) | (8.7) | (3.9) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | — | (33.6) | — | — | — | — | (17.4) | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | (0.2) | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||||
| Net Income | 36.8 | (33.6) | (21.8) | (29.8) | (29.0) | (15.9) | (17.4) | (13.2) | (11.9) | (9.8) | (3.9) |
| Per Share | |||||||||||
| Basic EPS | 6.48 | (28.42) | (6.32) | (15.07) | (15.22) | (0.59) | — | — | — | — | — |
| Basic Weighted Avg Shares | 5.7 | 1.2 | 3.4 | 2.0 | 1.9 | 26.9 | — | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | (25.0) | (26.5) | (29.5) | (30.5) | (22.8) | (19.5) | (17.3) | (15.0) | (8.6) | (3.9) |
| EBIT | (28.9) | (25.1) | (26.6) | (29.6) | (30.6) | (23.0) | (19.7) | (17.5) | (15.0) | (8.7) | (3.9) |
| Effective Tax Rate | — | — | — | — | — | — | 0.0% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.